Overview

A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-11-01

Target enrollment:

Participant gender:

Summary

This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.

Phase:

PHASE1

Details

Lead Sponsor:

AbbVie

Treatments:

Itraconazole